- Home
- CZNC vs SLP Comparison
CZNC vs SLP Comparison
Compare CZNC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- SLP
- Stock Information
- Founded
- CZNC 1864
- SLP 1996
- Country
- CZNC United States
- SLP United States
- Employees
- CZNC N/A
- SLP N/A
- Industry
- CZNC Major Banks
- SLP EDP Services
- Sector
- CZNC Finance
- SLP Technology
- Exchange
- CZNC Nasdaq
- SLP Nasdaq
- Market Cap
- CZNC 297.0M
- SLP 261.0M
- IPO Year
- CZNC N/A
- SLP 1997
- Fundamental
- Price
- CZNC $18.69
- SLP $14.17
- Analyst Decision
- CZNC
- SLP Buy
- Analyst Count
- CZNC 0
- SLP 7
- Target Price
- CZNC N/A
- SLP $29.50
- AVG Volume (30 Days)
- CZNC 44.8K
- SLP 1.1M
- Earning Date
- CZNC 08-15-2025
- SLP 07-14-2025
- Dividend Yield
- CZNC 5.99%
- SLP N/A
- EPS Growth
- CZNC 15.59
- SLP N/A
- EPS
- CZNC 1.75
- SLP N/A
- Revenue
- CZNC $108,310,000.00
- SLP $80,383,000.00
- Revenue This Year
- CZNC $5.72
- SLP $15.28
- Revenue Next Year
- CZNC $7.18
- SLP $0.79
- P/E Ratio
- CZNC $10.71
- SLP N/A
- Revenue Growth
- CZNC 4.96
- SLP 20.01
- 52 Week Low
- CZNC $17.85
- SLP $12.39
- 52 Week High
- CZNC $22.68
- SLP $37.72
- Technical
- Relative Strength Index (RSI)
- CZNC 43.87
- SLP 43.14
- Support Level
- CZNC $18.16
- SLP $12.62
- Resistance Level
- CZNC $19.10
- SLP $13.07
- Average True Range (ATR)
- CZNC 0.46
- SLP 0.51
- MACD
- CZNC -0.10
- SLP 0.46
- Stochastic Oscillator
- CZNC 28.96
- SLP 99.40
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.